CIC
PNT

Cornercap Investment Counsel’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Cornercap Investment Counsel’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,474
Closed -$190K – 667
2023
Q3 		$190K Sell
28,474
-373
-1% -$3.1K 0.03% 495
2023
Q2 		$261K Buy
+28,847
New +$254K 0.05% 475

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Cornercap Investment Counsel's PNT Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 28,474 shares — an estimated $190K sold.

Cornercap Investment Counsel first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $261K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 28,474 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $190K.
  • Cornercap Investment Counsel first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Cornercap Investment Counsel's POINT Biopharma Global Inc. Common Stock position peaked at $261K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.